Crossover Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Crossover Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Crossover Phase Today - Breaking & Trending Today

Takeda Receives Positive CHMP Opinion for Recombinant ADAMTS13 rADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura cTTP

Published: January 1, 2024

Takeda TSE4502NYSETAK today announced that the European Medicines Agencys EMA Committee for Medicinal Products for Human Use CHMP has recommended the approval under exceptional circumstances of recombinant ADAMTS13 rADAMTS13 for the treatment of ADAMTS13 deficiency in children and adult patients with cTTP.

Source: businesswireindia.com

Related Topics:

United StatesKremer HovingaJun SaitoVan DorlandThromb HaemostTakeda Pharmaceutical Company LimitedExchange CommissionJapanese Ministry Of HealthEuropean Medicines AgencyEuropean CommissionTreatment OptionsDrug AdministrationEuropean UnionFranchise Global Program Leader At TakedaCommittee For Medicinal Products Human UsePotentially Fatal Blood Clotting DisorderLimited Treatment OptionsMortality RateOnly RecombinantReplacement TherapyOpinion BasedIncluding ResultsFirst RandomizedCrossover PhaseMedicinal Products